Dr. Joan Seoane
VIEW MORE
Published in Molecular Cancer Therapeutics*, a journal of the American Association for Cancer Research (AACR), results of a study co-led...
Novel T cell bispecific antibody shows potent anti-tumor activity in preclinical models of epidermal growth factor receptor variant III (EGFRvIII) mutant glioblastoma
VIEW MORE
Founded by Cancer Research UK (CRUK) and the National Cancer Institute (NIH-NCI, USA) the Cancer Grand Challenges are internationally funded...
Cancer Grand Challenges’ annual celebration of scientific progress: the OPTIMISTICC team story and taking on the microbiota challenge
VIEW MORE
Results of a VHIO co-led retrospective study published in JCO Precision Oncology verify the use of diagnostic archival tissue biopsies...
Diagnostic tissue biopsy: informing biomarker-driven clinical decision making in advanced prostate cancer

Latest News

Published in the flagship journal of the European Society for Medical Oncology, Annals of Oncology, renowned leaders in the field…

+

Published in Molecular Cancer Therapeutics*, a journal of the American Association for Cancer Research (AACR), results of a study co-led…

+

Research Programs

PRECLINICAL & TRANSLATIONAL RESEARCH
Cellular Plasticity and Cancer Group

Our group focuses on the interplay between cellular plasticity, stem cells and cancer. Cellular plasticity is recognized today as a critical feature of cancer cells that enables them to transit between different cellular states, including reversible transitions.

Cellular Plasticity and Cancer Group
PRECLINICAL & TRANSLATIONAL RESEARCH
Growth Factors Group

We focus our research on mechanisms of resistance to targeted therapies and most importantly, how to overcome it by showing that breast cancers resistant to T-DM1, an antibody-drug conjugate ADC)- can be efficiently treated with the second generation ADC SYD985 (Nadal-Serrano et al.).

Growth Factors Group
CORE TECHNOLOGIES
Cancer Genomics Group

VHIO’s Cancer Genomics Group serves as a Core Technology laboratory. We are also dedicated to translational research as well as the development of novel genomic tests.

Cancer Genomics Group

PRINCIPAL RESEARCHERS

César_Serrano
César Serrano
Sarcoma Translational Research Group

Our group focuses on the study of sarcomas with oncogenic dependency on specific drivers of disease. Among these, gastrointestinal stromal…

Maria_Abad_profile_md
María Abad
Cellular Plasticity and Cancer Group

Nuestro grupo se centra en la interacción entre las respuestas al estrés, la plasticidad celular y el cáncer. La plasticidad…

RAQUEL_PEREZ
Raquel Pérez-López
Radiomics Group

Focused on applying imaging biomarkers and radiomics to cancer discovery, our efforts center on advancing precision imaging in personalized medicine…

Violeta_Serra
Violeta Sierra
Experimental Therapeutics Group

Our group conducts bench-to-bedside preclinical research in breast cancer to advance insights into biomarkers of response to targeted therapies. To…

Events

Friday 9 September 22 - 12:00 PM scientific-seminars Laura Fouassier I Pleotropic functions of EGFR in cholangiocarcinoma
Friday 23 September 22 - 12:00 PM scientific-seminars Jose-Javier Bravo-Cordero I High-resolution intravital microscopy reveals the plastic behavior of disseminated dormant cells and their niches
Thursday 13 October 22 - 11:00 AM Patients Surgery and breast cancer: when, how and on which patients can it be performed?
Friday 14 October 22 - 12:00 PM scientific-seminars Alejo Efeyan I TBC